Stifel Financial Corp Fulcrum Therapeutics, Inc. Transaction History
Stifel Financial Corp
- $86.8 Billion
- Q2 2024
A detailed history of Stifel Financial Corp transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 87,607 shares of FULC stock, worth $334,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,607
Previous 85,014
3.05%
Holding current value
$334,658
Previous $802,000
32.29%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding FULC
# of Institutions
135Shares Held
59.5MCall Options Held
4.32MPut Options Held
307K-
Ra Capital Management, L.P. Boston, MA11.6MShares$44.3 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$22.3 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$18.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$11.7 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$11.3 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $199M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...